Sign in Subscribe
Cancer research

UIC Researchers Awarded $1.2 Million Grant to Develop Personalized Prostate Cancer Treatments

Strategic Insights

— 1 min read

Researchers at the University of Illinois Chicago have been awarded a three-year, $1.2 million grant from the U.S. Department of Defense Prostate Cancer Research Program to study the variability in the effects of approved treatments for metastatic prostate cancer. The project will leverage data science methods to analyze clinical trial data and develop a web-based tool that provides personalized estimates of treatment effectiveness. This innovative approach aims to help clinicians select and personalize treatments to optimize safety and maximize efficacy for individual patients.

Key Takeaways:

  • The grant will fund a three-year research project to study the variation in the effects of approved treatments for metastatic prostate cancer.
  • The researchers will reanalyze clinical trial data from two trials, Latitude and TITAN, using cutting-edge machine-learning methods to uncover factors that drive variability in treatment effectiveness.
  • The project aims to develop a web-based data tool that allows users to input factors such as age and tumor characteristics to receive personalized estimates of treatment effectiveness.
  • The researchers will incorporate real-world electronic health record data to examine the effectiveness of these regimens in routine care populations.
  • The ultimate goal is to develop a clinical-decision support tool that will help providers select and personalize treatments to optimize safety and maximize efficacy.
  • Researchers from Northwestern University and the Moffitt Cancer Center in Tampa, Florida, are partnering with UIC researchers on the project.

Statistics:

  • The $1.2 million grant is a three-year award from the U.S. Department of Defense Prostate Cancer Research Program.
  • The project involves the reanalysis of clinical trial data from two trials, Latitude and TITAN, which included over 1,500 patients.
  • The researchers aim to develop a web-based data tool that will be accessible to clinicians and patients nationwide.
  • The project is expected to lead to improved personalized treatment plans for patients diagnosed with metastatic prostate cancer.

Sources:

  • University of Illinois Chicago news release, no date provided.
  • U.S. Department of Defense Prostate Cancer Research Program.

Read more